The trajectory of companies tied to the drug's past presents a challenging investment landscape. While the initial surge generated substantial gains, generic alternatives have significantly eroded sales . https://bookmarkingace.com/story21649263/copyright-s-flagship-product-and-pharma-a-uncertain-opportunity